Syndax Pharmaceuticals Stock Price Prediction
| SNDX Stock | USD 16.72 0.21 1.27% |
Oversold Vs Overbought
33
Oversold | Overbought |
Using Syndax Pharmaceuticals hype-based prediction, you can estimate the value of Syndax Pharmaceuticals from the perspective of Syndax Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Syndax Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Syndax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Syndax Pharmaceuticals after-hype prediction price | USD 16.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Syndax |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Syndax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Syndax Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Syndax Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Syndax Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Syndax Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Syndax Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Syndax Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Syndax Pharmaceuticals' historical news coverage. Syndax Pharmaceuticals' after-hype downside and upside margins for the prediction period are 12.58 and 20.86, respectively. We have considered Syndax Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Syndax Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Syndax Pharmaceuticals is based on 3 months time horizon.
Syndax Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Syndax Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Syndax Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Syndax Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 4.14 | 0.00 | 0.04 | 0 Events / Month | 7 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.72 | 16.72 | 0.00 |
|
Syndax Pharmaceuticals Hype Timeline
Syndax Pharmaceuticals is at this time traded for 16.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.04. Syndax is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.23%. %. The volatility of related hype on Syndax Pharmaceuticals is about 2658.72%, with the expected price after the next announcement by competition of 16.76. About 99.0% of the company shares are owned by institutional investors. The book value of Syndax Pharmaceuticals was at this time reported as 4.28. The company has Price/Earnings (P/E) ratio of 126.11. Syndax Pharmaceuticals recorded a loss per share of 3.64. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be within a week. Check out Syndax Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Syndax Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Syndax Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Syndax Pharmaceuticals' future price movements. Getting to know how Syndax Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Syndax Pharmaceuticals may potentially react to the hype associated with one of its peers.
Syndax Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Syndax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Syndax using various technical indicators. When you analyze Syndax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Syndax Pharmaceuticals Predictive Indicators
The successful prediction of Syndax Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Syndax Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Syndax Pharmaceuticals based on analysis of Syndax Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Syndax Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Syndax Pharmaceuticals's related companies.
Story Coverage note for Syndax Pharmaceuticals
The number of cover stories for Syndax Pharmaceuticals depends on current market conditions and Syndax Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Syndax Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Syndax Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Syndax Pharmaceuticals Short Properties
Syndax Pharmaceuticals' future price predictability will typically decrease when Syndax Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Syndax Pharmaceuticals often depends not only on the future outlook of the potential Syndax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Syndax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.4 M | |
| Cash And Short Term Investments | 577.6 M |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.